Gensight Biologics SA buy Lokrim
Start price
21.12.19
/
50%
€2.45
Target price
12.01.20
-
Performance (%)
65.92%
End price
12.01.20
€4.07
Summary
This prediction ended on 12.01.20 with a price of €4.07. With a performance of 65.92% the BUY prediction by Lokrim was a big success. Lokrim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Gensight Biologics SA | 1.552% | 1.552% | -39.893% | -94.767% |
iShares Core DAX® | 1.804% | -0.748% | 13.168% | 16.408% |
iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% | 43.502% |
iShares Nikkei 225® | 0.413% | -7.381% | 18.776% | 2.874% |
iShares S&P 500 | 0.664% | -1.941% | 28.141% | 42.155% |
According to Lokrim what are the pros and cons of Gensight Biologics SA for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Lokrim for this prediction
In the thread Gensight Biologics SA diskutieren
Buy Gensight Biologics SA
Buy beendet
Stopped prediction by Lokrim for Gensight Biologics SA
Gensight Biologics SA
Start price
Target price
Perf. (%)
€2.97
07.03.22
07.03.22
-
07.03.23
07.03.23
-19.53%
08.03.23
08.03.23
Risky Investment
Gensight Biologics SA
Start price
Target price
Perf. (%)
€4.07
12.01.20
12.01.20
-
04.11.21
04.11.21
35.92%
05.11.21
05.11.21
Risky Investment